Hymenoptera Venom Immunotherapy: Tolerance and Efficacy of an Ultrarush Protocol versus a Rush and a Slow Conventional Protocol

Background and Objective. Various venom immunotherapy (VIT) protocols are available for Hymenoptera allergy. Although adverse reactions (ADRs) to VIT are widely reported, controlled trials are still needed. We conducted a randomized prospective study to evaluate ADRs and the efficacy of three VIT regimens. Methods. 76 patients with Hymenoptera allergy, aged 16–76 years, were randomized to receive an ultrarush protocol (group A: 27 patients), a rush protocol (group B: 25), or a slow protocol (group C: 24). Aqueous venom extract was used in incremental phase and an adsorbed depot in maintenance phase. ADRs and accidental Hymenoptera stings during VIT were used to evaluate efficacy. Results. During incremental treatment, ADRs occurred in 1.99%, 3.7%, and 3.9% of patients in groups A, B, and C, and in 0.99%, 1.46%, and 2.7%, respectively, during maintenance. ADRs were significantly fewer in group A (incremental + maintenance phase) than in group C (1.29% versus 3.2%; P = 0.013). Reactions to accidental Hymenoptera stings did not differ among groups (1.1%, 1.2%, and 1.1%). Conclusion. Ultrarush was as effective as the rush and slow protocols and was associated with a low incidence of reactions to stings. This study indicates that ultrarush VIT is a valid therapeutic option for Hymenoptera allergy

Proteomic Analysis of Sera from Common Variable Immunodeficiency Patients Undergoing Replacement Intravenous Immunoglobulin Therapy

Common variable immunodeficiency is the most common form of symptomatic primary antibody failure in adults and children. Replacement immunoglobulin is the standard treatment of these patients. By using a differential proteomic approach based on 2D-DIGE, we examined serum samples from normal donors and from matched, naive, and immunoglobulin-treated patients. The results highlighted regulated expression of serum proteins in naive patients. Among the identified proteins, clusterin/ApoJ serum levels were lower in naive patients, compared to normal subjects. This finding was validated in a wider collection of samples from newly enrolled patients. The establishment of a cellular system, based on a human hepatocyte cell line HuH7, allowed to ascertain a potential role in the regulation of CLU gene expression by immunoglobulins

Expression and Functions of the Vascular Endothelial Growth Factors and Their Receptors in Human Basophils

Abstract Angiogenesis is a multistep complex phenomenon critical for several inflammatory and neoplastic disorders. Basophils, normally confined to peripheral blood, can infiltrate the sites of chronic inflammation. In an attempt to obtain insights into the mechanism(s) underlying human basophil chemotaxis and its role in inflammation, we have characterized the expression and function of vascular endothelial growth factors (VEGFs) and their receptors in these cells. Basophils express mRNA for three isoforms of VEGF-A (121, 165, and 189) and two isoforms of VEGF-B (167 and 186). Peripheral blood and basophils in nasal polyps contain VEGF-A localized in secretory granules. The concentration of VEGF-A in basophils was 144.4 ± 10.8 pg/106 cells. Immunologic activation of basophils induced the release of VEGF-A. VEGF-A (10–500 ng/ml) induced basophil chemotaxis. Supernatants of activated basophils induced an angiogenic response in the chick embryo chorioallantoic membrane that was inhibited by an anti-VEGF-A Ab. The tyrosine kinase VEGFR-2 (VEGFR-2/KDR) mRNA was expressed in basophils. These cells also expressed mRNA for the soluble form of VEGFR-1 and neuropilin (NRP)1 and NRP2. Flow cytometric analysis indicated that basophils express epitopes recognized by mAbs against the extracellular domains of VEGFR-2, NRP1, and NRP2. Our data suggest that basophils could play a role in angiogenesis and inflammation through the expression of several forms of VEGF and their receptors

Resolving forward-reverse logistics multi-period model using evolutionary algorithms

© 2016 Elsevier Ltd In the changing competitive landscape and with growing environmental awareness, reverse logistics issues have become prominent in manufacturing organizations. As a result there is an increasing focus on green aspects of the supply chain to reduce environmental impacts and ensure environmental efficiency. This is largely driven by changes made in government rules and regulations with which organizations must comply in order to successfully operate in different regions of the world. Therefore, manufacturing organizations are striving hard to implement environmentally efficient supply chains while simultaneously maximizing their profit to compete in the market. To address the issue, this research studies a forward-reverse logistics model. This paper puts forward a model of a multi-period, multi-echelon, vehicle routing, forward-reverse logistics system. The network considered in the model assumes a fixed number of suppliers, facilities, distributors, customer zones, disassembly locations, re-distributors and second customer zones. The demand levels at customer zones are assumed to be deterministic. The objective of the paper is to maximize the total expected profit and also to obtain an efficient route for the vehicle corresponding to an optimal/near optimal solution. The proposed model is resolved using Artificial Immune System (AIS) and Particle Swarm Optimization (PSO) algorithms. The findings show that for the considered model, AIS works better than the PSO. This information is important for a manufacturing organization engaged in reverse logistics programs and in running units efficiently. This paper also contributes to the limited literature on reverse logistics that considers costs and profit as well as vehicle route management

New records of snipe eels (Anguilliformes: Nemichthyidae) from the Pacific coast of lower Central America

Background: New records of occurrence of two snipe eels (Avocettina bowersii and Nemichthys scolopaceus), poorly known for the Pacific coast of Costa Rica and Panama are herein reported. Results: Specimens, 45 in total (28 and 17, respectively), were collected between 1972 and 1973 at depths between 295 and 1000 m. Descriptions based on specimens as well as comparative morphometric and distributional information by species are herein presented and discussed. A key to the identification of the eastern Pacific species of the family also is presented. Conclusion: These findings increase the knowledge on the Central American marine ichthyofauna and provide evidence of a broader distributional pattern for these species in the eastern Pacific region.UCR::Vicerrectoría de Investigación::Unidades de Investigación::Ciencias Básicas::Centro de Investigación en Ciencias del Mar y Limnología (CIMAR